Skip to main content
SpringerLink
Log in

Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis

  • Original Article
  • Published:
Journal of Orthopaedic Science

Abstract

Background

Recent advances in the understanding of blood coagulation processes favor an inflammatory basis for thrombotic events. In this study, thrombotic risk after total knee arthroplasty (TKA) was assessed and compared between patients with rheumatoid arthritis (RA) and those with osteoarthritis (OA).

Methods

Subjects comprised 199 patients (238 knees) with RA and 156 patients (169 knees) with OA. Serum D-dimer levels were measured before and after the operation. Lowdose unfractionated heparin was given for 7 days when patients had a history of previous venous thromboembolism or had a D-dimer level or ≥10 μg/ml of D-dimer on postoperative day 1. Doppler ultrasonography (DUS) was routinely performed preoperatively and on postoperative day (POD) 7 for diagnosing a deep venous thrombosis (DVT).

Results

D-dimer levels on PODs 0, 1, and 7 were, respectively, 4.6, 37.2, and 11.2 μg/ml for RA and 1.8, 42.3, and 13.6 μg/ml for OA. The incidence of DUS-confirmed DVT was 20.6% in the RA group and 43.2% in the OA group, indicating a much higher incidence of postoperative DVT in OA patients (P < 0.001). Interestingly, when patients taking nonsteroidal antiinflammatory drugs (NSAIDs) or those >65 years of age were excluded, the incidence of DVT was comparable in the RA and OA groups. Symptomatic pulmonary embolism and DVT occurred in two and one OA patients and in one and two RA patients, respectively, with one postdischarge DVT included in each group.

Conclusions

The present study revealed that the incidence of DVT following TKA was significantly lower in RA patients than in those with OA. However, when the patients were matched for age and NSAID use, the incidence of DVT was equivalent in the two groups. These findings may allow us to reconsider a prophylactic regimen for venous thromboembolism in patients with RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of thromboembolism. Chest 2004;126(suppl):338S–400S.

    Article  PubMed  CAS  Google Scholar 

  2. Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T. Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop 2000;375:168–174.

    Article  PubMed  Google Scholar 

  3. Russel MW, Taylor DCA, Cumminus G, Huse DM. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients. Am J Manag Care 2002;8:S3–S9.

    Google Scholar 

  4. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.

    Article  PubMed  CAS  Google Scholar 

  5. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006;72:1605–1621.

    Article  PubMed  CAS  Google Scholar 

  6. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004;99:97–101.

    Article  PubMed  Google Scholar 

  7. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a populationbased cohort study. Thromb Haemost 2001;85:430–434.

    PubMed  CAS  Google Scholar 

  8. Van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520–2526.

    PubMed  Google Scholar 

  9. Psuja P, Zozulinska M, Turowiecka Z, Cieslikowski W, Vinazzer H, Zawilska K. Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock. Clin Appl Thromb Hemost 2002;8:225–230.

    Article  PubMed  CAS  Google Scholar 

  10. So AK, Varisco PA, Kemkes-Matthes B, Herkenne-Morard C, Chobaz-Peclat V, Gerster JC, et al. Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways. J Thromb Haemost 2003;1:2510–2515.

    Article  PubMed  CAS  Google Scholar 

  11. Seriolo B, Accardo S, Garnero A, Fasciolo D, Cutolo M. Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patients. Rheumatology (Oxford) 1999;38:675–678.

    Article  CAS  Google Scholar 

  12. Seriolo B, Accardo S, Fasciolo D, Bertolini S, Cutolo M. Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis. Clin Exp Rheumatol 1996;14:593–599.

    PubMed  CAS  Google Scholar 

  13. Fort JG, Cowchock FS, Abruzzo JL, Smith JB. Anticardiolipin antibodies in patients with rheumatic diseases. Arthritis Rheum 1987;30:752–760.

    Article  PubMed  CAS  Google Scholar 

  14. Buchanan RR, Kraag G. Is there a lower incidence of deep venous thrombosis after joint replacement in rheumatoid arthritis? J Rheumatol 1980;7:551–554.

    PubMed  CAS  Google Scholar 

  15. Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg Br 1981;63:171–177.

    PubMed  Google Scholar 

  16. Van Heereveld HA, Laan RF, van den Hoogen FH, Malefijt MC, Novakova IR, van de Putte LB. Prevention of symptomatic thrombosis with short term (low molecular weight) heparin in patients with rheumatoid arthritis after hip or knee replacement. Ann Rheum Dis 2001;60:974–976.

    Article  PubMed  Google Scholar 

  17. Colwell CW Jr, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, et al. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am 2005;87:2169–2177.

    Article  PubMed  Google Scholar 

  18. Salzman EW, Hirsh J. The epidemiology, pathogenesis and natural history of venous thrombosis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott; 1994. p. 1275–1296.

    Google Scholar 

  19. Rao LV, Rapaport SI, Bajaj SP. Activation of human factor VII in the initiation of tissue factor-dependent coagulation. Blood 1986;68:685–691.

    PubMed  CAS  Google Scholar 

  20. Fair DS, MacDonald MJ. Cooperative interaction between factor VII and cell surface-expressed tissue factor. J Biol Chem 1987;262:11692–11698.

    PubMed  CAS  Google Scholar 

  21. Mackman N. Regulation of tissue factor gene expression in human monocytic and endothelial cells. Haemostasis 1996;26(suppl 1):17–19.

    PubMed  CAS  Google Scholar 

  22. Bierhaus A, Zhang Y, Deng Y, Mackman N, Quehenberger P, Haase M, et al. Mechanism of the tumor necrosis factor alphamediated induction of endothelial tissue factor. J Biol Chem 1995;270:26419–26432.

    Article  PubMed  CAS  Google Scholar 

  23. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000;20:2322–2328.

    PubMed  CAS  Google Scholar 

  24. Esmon CT. The interactions between inflammation and coagulation. Br J Haematol 2005;131:417–430.

    Article  PubMed  CAS  Google Scholar 

  25. Conway EM, Rosenberg RD. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 1988;8:5588–5592.

    PubMed  CAS  Google Scholar 

  26. Fukudome K, Esmon CT. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994;269:26486–26491.

    PubMed  CAS  Google Scholar 

  27. Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties: modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989;264:20705–20713.

    PubMed  CAS  Google Scholar 

  28. Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M. Targeting TNF alpha for the therapy of rheumatoid arthritis. Clin Exp Rheumatol 1994;12(suppl 11):S63–S66.

    PubMed  Google Scholar 

  29. Kopeikina LT, Kamper EF, Koutsoukos V, Bassiakos Y, Stavridis I. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity. Clin Rheumatol 1997;16:254–260.

    Article  PubMed  CAS  Google Scholar 

  30. Vayá A, Mira Y, Martínez M, Villa P, Ferrando F, Estellés A, et al. Biological risk factors for deep vein thrombosis. Clin Hemorheol Microcirc 2002;26:41–53.

    PubMed  Google Scholar 

  31. Banyai S, Banyai M, Koppensteiner R. Blood rheology in deep venous thrombosis: relation to persistent and transient risk factors. Thromb Res 2002;15;107:101–107.

    Google Scholar 

  32. Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW, Khuri S, Henderson WG, et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007;45:335–341.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan

    Yasuo Niki & Akihiro Hakozaki

  2. Institute of Rheumatology, Tokyo Women’s Medical College, Tokyo, Japan

    Yasuo Niki, Takeshi Mochizuki & Shigeki Momohara

  3. Institute for Integrated Sports Medicine, Keio University, Tokyo, Japan

    Hideo Matsumoto

Authors
  1. Yasuo Niki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideo Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akihiro Hakozaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takeshi Mochizuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeki Momohara
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Niki, Y., Matsumoto, H., Hakozaki, A. et al. Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis. J Orthop Sci 15, 57–63 (2010). https://doi.org/10.1007/s00776-009-1410-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-009-1410-3

Keywords

Search

Navigation